Great West Life Assurance CO Arcus Biosciences, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 58,852 shares of RCUS stock, worth $984,593. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,852
Previous 46,426
26.77%
Holding current value
$984,593
Previous $876,000
2.17%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RCUS
# of Institutions
207Shares Held
49MCall Options Held
173KPut Options Held
151K-
Black Rock Inc. New York, NY9.76MShares$163 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$88 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA4.25MShares$71 Million0.65% of portfolio
-
State Street Corp Boston, MA3.06MShares$51.1 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.83MShares$30.7 Million0.08% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $1.21B
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...